No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Established in 1996 and headquartered in Gurugram, India, Fortis Healthcare Limited operates as an integrated provider of healthcare services. The company extends its offerings, which encompass secondary, tertiary, and quaternary medical care, across India, the United Arab Emirates, Sri Lanka, and other international markets. Its diverse healthcare infrastructure includes a network of hospitals, diagnostic facilities, and specialized day-care centers. Fortis delivers expertise across a broad spectrum of medical disciplines, including cardiology, cosmetic and dental sciences, dermatology, endocrinology, emergency medicine, ENT, fetal medicine, gastroenterology and hepatology, general surgery, haematology, infertility treatment, internal medicine, mental and behavioral health, nephrology, neurosurgery, neurointervention, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy, plastic surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplant medicine, urology, and numerous other supporting specialties. By March 31, 2022, the company managed 26 hospitals, housing approximately 4,300 operational beds, in addition to around 426 diagnostic centers and laboratories, complemented by 2,550 collection centers.
www.fortishealthcare.comNo one on the platform currently holds FORTIS.NS.
No tracked institution reports a position in FORTIS.NS as of their last filing.
No one on the platform has traded FORTIS.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.8% | 24.1% | — | — | — | |
| Rev. Growth % | 17.2% | 17.8% | ||||
| Profit Margin % | 11.4% | 9.8% | 2.8% | |||
| Free Cash Flow Margin % | 4.8% | 6.4% | 5.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $106.6B | +16.6% | $17.16 | $15.94–$18.46 | — | 15 |
| 2028 | $122.2B | +14.7% | $22.76 | $20.06–$26.95 | — | 18 |
| 2029 | $139.5B | +14.2% | $27.73 | $25.03–$34.79 | — | 11 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $3.85 | $3.42 | -11.2% |
| 2026-05-22 | $3.97 | $3.70 | -6.8% |
| 2026-02-13 | $3.42 | $3.18 | -7.0% |
| 2025-11-11 | $3.56 | $3.99 | +12.1% |
| 2025-08-06 | $2.98 | $3.35 | +12.4% |
| 2025-05-20 | $2.70 | $2.39 | -11.5% |
| 2025-02-07 | $2.24 | $3.00 | +33.9% |
| 2024-11-08 | $2.69 | $3.02 | +12.3% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| FORTIS.NSFortis Healthcare Limited | $885.40 | -0.27% | $668.4B | — |
| ALKEM.BOAlkem Laboratories Limited | $5284.55 | +3.83% | $630.9B | — |
| ALKEM.NSAlkem Laboratories Limited | $5277.00 | +3.72% | $630.9B | — |
| APOLLOHOSP.BOApollo Hospitals Enterprise Limited | $8815.35 | -0.39% | $1.27T | — |
| APOLLOHOSP.NSApollo Hospitals Enterprise Limited |
| $8814.50 |
| -0.24% |
| $1.27T |
| — |
| ASTERDM.NSAster DM Healthcare Limited | $752.80 | -1.34% | $389.2B | — |
| MAXHEALTH.BOMax Healthcare Institute Ltd | $1032.50 | -0.45% | $1.00T | — |
Source: Financial Modeling Prep · peers by sector/industry